Journals / Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi / 2013 / Cilt: 10 - Sayı: 38

ÖNCEKİ MULTİLOAD 375 RAHİM İÇİ ARAÇ ATILIMI LEVONORGESTREL SALGILAYAN RAHİM İÇİ ARAÇ İÇİN RİSK FAKTÖRÜ MÜDÜR?

IS HISTORY OF PREVIOUS MULTILOAD 375 IUD EXPULSION A RISK FACTOR FOR LEVONORGESTREL-RELEASING INTRAUTERINE DEVICE USERS?

Pages
1582–1585
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

With a very low dislocation rate LNG-IUD might provide a higher contraceptive efficacy than other IUDs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Although intrauterine devices (IUDs) is one of the most frequently used contraceptive methods, the pregnancy rate is estimated between 1 and 3 per 100 woman-years.
📊
Key Findings & Data:Third generation copper IUDs and the levonorgestrel-releasing device (LNG-IUD) are both safer than conventional IUDs with a low failure rate.
💡
Conclusion & Impact:With a very low dislocation rate LNG-IUD might provide a higher contraceptive efficacy than other IUDs.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Although intrauterine devices (IUDs) is one of the most frequently used contraceptive methods, the pregnancy rate is estimated between 1 and 3 per 100 woman-years. Third generation copper IUDs and the levonorgestrel-releasing device (LNG-IUD) are both safer than conventional IUDs with a low failure rate. The contraceptive efficacy of an IUD is thought to be related to its position in the uterine cavity. In previous reports expulsion was associated with a significantly higher risk for a re-expulsion in IUD patients. Although several trials examined the rate of multiload 375 IUD and LNG-IUD expulsions, none have evaluated the partial and complete expulsion rates of the LNG-IUD in previously dislocated multiload 375 IUD users. Materials and method: This prospective study involved a total of 127 LNG-IUD inserted patients. In 57 patients Multiload 375 IUD have previously dislocated (n=57, study group) and in 70 patients IUD have never been applicated (control group). Transvaginal ultrasound was used to monitor the LNG-IUD position immediately after insertion, 10 days after and later on at 6 months intervals for a 2 years follow-up. Results: Demographic characteristics of groups were similar. Hypermenorrhea was not found to be associated with an increased dislocation rate in LNG-IUD users. We detected only one dislocation in study group and two dislocations in control group (1,8% vs 2.8%, p>0.05). Conclusion: History of previous Multiload 375 IUD expulsion was not found to be a risk factor for LNG-IUD failure. With a very low dislocation rate LNG-IUD might provide a higher contraceptive efficacy than other IUDs.

Özet

Amaç: Rahim içi araç (RİA), en sık kullanılan doğum kontrol yöntemleri biri olarak kullanılmasına karşın gebelik oranı yıl başına 1-3/100 kadın olarak tahmin edilmektedir.. Üçüncü nesil bakır RİA ve levonorgestrel salan cihaz (LNG-RİA) gebelik oranlarının düşüklüğü ile geleneksel RİAdan daha güvenlidir. RİAnın gebelik önleyici etkinliği rahim boşluğu içindeki konumu ile ilgilidir. Önceki yayınlarda multiload 375 RİA ve LNGRİA yerinden çıkmaları değerlendirilmişse de, daha önce multiload 375 RİA çıkmış olanlarda, LNG-RİAnın tam çıkma ya da kısmi yer değiştirmeleri incelenmemiştir Gereçler ve Yöntem: Bu prospektif çalışma toplam 127 LNG-IUD takılmış hastayı içermektedir. 127 hastanın çalışma grubunu oluşturan 57sinde daha önce Multiload 375 RİA atılımı öyküsü mevcutken(çalışma grubu), 70 hastada daha önceden RİA atılımı öyküsü yoktur (kontrol grubu). LNG-RİA konumunu izlemek için transvajinal ultrasound RİA takılmasından sonraki 10. gün, 6 aylık aralıklarla ve toplamda 2 yıllık izlemler olacak şekilde değerlendirilmiştir. Bulgular: Grupların demografik özellikleri benzerdir. Hipermenore, LNG-RİA kullananlarda artmış yer değiştirme ile ilişkili bulunmadı. Çalışma grubunda bir LNG RİA atılımı ve kontrol grubunda iki atılım((% 1,8'e karşılık % 2.8, p> 0.05) tespit edildi. Sonuç: Önceki Multiload 375 RİA atılımı LNG-RİA başarısızlığı için bir risk faktörü olarak bulunmamıştır. Yerinden oynama riskinin çok düşük olduğu LNG-RİA, diğer RİAlardan daha yüksek kontraseptif etkinlik sağlayabilir.

🔖

Cite This Article

ÖZTÜRK, N. T., AKER, A. A. (2022). ÖNCEKİ MULTİLOAD 375 RAHİM İÇİ ARAÇ ATILIMI LEVONORGESTREL SALGILAYAN RAHİM İÇİ ARAÇ İÇİN RİSK FAKTÖRÜ MÜDÜR?. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, Cilt: 10 - Sayı: 38, 1582–1585. https://ajindex.com/articles/558940

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Luukkainen T, Lahteenmaki P, Toivonen J. Levonorgestrel-releasing intrauterine device. Ann Med 1990; 22:85–90
  2. Luukkainen T. Levonorgestrel-releasing intrauterine device. Ann NY Acad Sci 1991; 626:43–9
  3. Sivin I, el Mahgoub S, McCarthy T, et al. Longterm contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Contraception 1990;42:361– 78
  4. Thonneau P, Goulard H, Goyaux N. Risk factors for intrauterine device failure: a review. Contraception 2001;64:33–7
  5. Petta CA, Faundes D, Pimentel E, Diaz J, Bahamondes L. The use of vaginal ultrasound to identify copper T IUDs at high risk of expulsion. Contraception 1996;54:287–9
  6. Rivera R, Chen-Mok M, McMullen S. Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD. Contraception 1999;60:155–60
  7. Bahamondes L, Diaz J, Marchi NM, Petta CA, Cristofoletti ML, Gomez G. Performance of copper intrauterine devices when inserted after an expulsion. Hum Reprod 1995;10:2917–8
  8. Castro A, Abarca L, Rios M. The clinical performance of the Multiload IUD. I. The influence of the endometrial cavity length. Adv Contracept 1993;9:285–90
  9. Zhang J. Factors associated with copper T IUD removal for bleeding/pain: a multivariate analysis. Contraception 1993;48:13–21
  10. Anteby E, Revel A, Ben-Chetrit A, Rosen B, Tadmor O, Yagel S. Intrauterine device failure: relation to its location within the uterine cavity. Obstet Gynecol 1993;81:112–4
  11. NICE. National Institute for Health and Clinical Excellence. Long-acting Reversible Contraception (2005
  12. Suhonen S, Haukkamaa M, Jakobsson T, Rauramo I. Clinical performance of a levonorgestrelreleasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study. Contraception 2004; 69:407–12
  13. Baveja R, Bichille LK, Coyaji KJ, et al. Randomized clinical trial with intrauterine devices (levonorgestrel intrauterine device (LNG), CuT 380Ag, CuT 220C and CuT 200B). A 36-month study. Indian Council of Medical Research Task Force on IUD. Contraception 1989;39:37–52
  14. Andersson K, Odlind V, Rybo G. Levonorgestrelreleasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 1994;49:56–72
  15. Sivin I, Stern J, Coutinho E, et al. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/ day (LNg 20) and the copper T380 Ag IUDs. Contra